NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
NCT 05020678 Brief Summary This is a single arm, open-label, multi-center, Phase…
Read more arrow_forwardNCT 05020678 Brief Summary This is a single arm, open-label, multi-center, Phase…
Read more arrow_forwardNCT 05020678 Brief Summary This is a single arm, open-label, multi-center, Phase…
Read more arrow_forwardNCT 04986852 Brief Summary The objective is to evaluate the efficacy and…
Read more arrow_forwardNCT 06343402 Brief Summary A first in human study to evaluate the…
Read more arrow_forwardNCT 05735080 Brief Summary Incyclix Bio (Incyclix) is developing INX-315 as an…
Read more arrow_forwardNCT 06816992 Brief Summary The purpose of this study is to establish…
Read more arrow_forwardNCT 06536257 Brief Summary This is a non-interventional study to prospectively test…
Read more arrow_forwardNCT 06092580 Brief Summary The aims of this clinical trial are (1)…
Read more arrow_forwardNCT 03212404 Brief Summary CK-301 (cosibelimab) is a fully human monoclonal antibody…
Read more arrow_forwardNCT 06840119 Brief Summary This phase 1/2 first-in-human study is designed to…
Read more arrow_forward